These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16729392)

  • 1. Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation.
    Wahie S; Alexandroff A; Reynolds NJ; Meggit SJ
    Br J Dermatol; 2006 Jan; 154(1):194-5. PubMed ID: 16729392
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma.
    Verdonck LF
    J Clin Oncol; 1999 Sep; 17(9):3003. PubMed ID: 10627188
    [No Abstract]   [Full Text] [Related]  

  • 3. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
    Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
    J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
    Okada S
    Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
    Reimer P; Schertlin T; Rüdiger T; Geissinger E; Roth S; Kunzmann V; Weissinger F; Nerl C; Schmitz N; Müller-Hermelink HK; Wilhelm M
    Hematol J; 2004; 5(4):304-11. PubMed ID: 15297846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
    Fisher RI
    J Natl Cancer Inst; 2001 Jan; 93(1):4-5. PubMed ID: 11136829
    [No Abstract]   [Full Text] [Related]  

  • 8. Who should receive myeloablative therapy for lymphoma?
    Lister TA
    N Engl J Med; 2004 Mar; 350(13):1277-8. PubMed ID: 15044635
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell lymphoma in the parotid region after cardiac transplant: case report.
    Mandel L; Surattanont F; Dourmas M
    J Oral Maxillofac Surg; 2001 Jun; 59(6):673-7. PubMed ID: 11381393
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Burke HB
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637756
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Nimer SD; Zelenetz A; Portlock C
    N Engl J Med; 1995 Sep; 333(11):728-9; author reply 730. PubMed ID: 7503899
    [No Abstract]   [Full Text] [Related]  

  • 14. [New therapy of patients with malignant lymphoma using G-CSF].
    Asano S
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Fielding AK; Pearce RM; Goldstone AH
    N Engl J Med; 1995 Sep; 333(11):729; author reply 730. PubMed ID: 7637758
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
    Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
    Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
    Park BB; Kim WS; Lee J; Park KW; Kang JH; Lee SH; Park JO; Kim K; Jung CW; Park YS; Im YH; Kang WK; Ko YH; Lee MH; Park K
    Leuk Lymphoma; 2005 Dec; 46(12):1743-8. PubMed ID: 16263576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor.
    Ichii M; Hatanaka K; Imakita M; Ueda Y; Kishino B; Tamaki T
    Leuk Lymphoma; 2006 Oct; 47(10):2250-2. PubMed ID: 17071503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.